This company has been marked as potentially delisted and may not be actively trading. NASDAQ:VICL Vical (VICL) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Vical Stock (NASDAQ:VICL) 30 days 90 days 365 days Advanced Chart Remove Ads Get Vical alerts:Sign Up Key Stats Today's Range N/A50-Day Range$0.68▼$3.1552-Week Range N/AVolume35,024 shsAverage Volume1.44 million shsMarket Capitalization$21.01 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewVical Incorporated researches and develops biopharmaceutical products based on its DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases. The company was founded in 1987 and is headquartered in San Diego, California.Read More… Remove Ads Receive VICL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Vical and its competitors with MarketBeat's FREE daily newsletter. Email Address VICL Stock News HeadlinesFresh Tracks Therapeutics (FRTX) Earnings Dates & ReportsMay 26, 2024 | investing.comEvan Gershkovich’s sister was the quiet one. Now she’s his voice.March 29, 2024 | msn.comTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.April 5, 2025 | Porter & Company (Ad)Song Suffragettes celebrates 10 years with Wynonna, female country chart-toppers, moreMarch 29, 2024 | msn.comSong lyrics getting simpler, more repetitive, angry and self-obsessed – studyMarch 29, 2024 | theguardian.comBeyoncé’s Younger Daughter Rumi Carter Joins Her on New Song ‘Protector’March 29, 2024 | msn.comBeyoncé features Shaboozey on her song 'Spaghettii': Who is the hip-hop, country artist?March 29, 2024 | msn.comCreed frontman Scott Stapp on singing his 'life story,' moving to Nashville and finding a dream teamMarch 28, 2024 | msn.comSee More Headlines VICL Stock Analysis - Frequently Asked Questions How were Vical's earnings last quarter? Vical Incorporated (NASDAQ:VICL) released its earnings results on Tuesday, February, 19th. The biotechnology company reported ($0.17) earnings per share for the quarter, hitting the consensus estimate of ($0.17). The biotechnology company earned $0.12 million during the quarter, compared to analysts' expectations of $0.04 million. Vical had a negative trailing twelve-month return on equity of 29.46% and a negative net margin of 1,002.10%. What other stocks do shareholders of Vical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Vical investors own include Caladrius Biosciences (CLBS), Catalyst Pharmaceuticals (CPRX), Inovio Pharmaceuticals (INO), Cytori Therapeutics (CYTX), Synergy Pharmaceuticals (SGYP), CTI BioPharma (CTIC) and Idera Pharmaceuticals (IDRA). Company Calendar Last Earnings2/19/2019Today4/04/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Biological Products, Except Diagnostic Sub-IndustryBiotechnology Current SymbolNASDAQ:VICL CIK819050 Webwww.vical.com Phone858-646-1100FaxN/AEmployees30Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.81) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-16,250,000.00 Net Margins-1,002.10% Pretax MarginN/A Return on Equity-29.46% Return on Assets-27.85% Debt Debt-to-Equity RatioN/A Current Ratio36.84 Quick Ratio36.84 Sales & Book Value Annual Sales$1.62 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value$1.82 per share Price / BookN/AMiscellaneous Outstanding Shares22,840,000Free FloatN/AMarket Cap$21.01 million OptionableNot Optionable Beta0.32 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free Report This page (NASDAQ:VICL) was last updated on 4/5/2025 by MarketBeat.com Staff From Our PartnersFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredAll Signs Point To Collapse - 401(k)s/IRAs /Are DoomedRetiring? Not so Fast..Hold Onto Your Bootstraps For A Long Road AheadAmerican Hartford Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vical Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Vical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.